Pharmaceutical compounds

Details Pharmaceutical compounds Pharmaceutical compounds

1994-03-21

1996-05-07

Hollinden, Gary E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514406, 514422, 5483351, 5483644, 548525, C07D31122, A61K 3135

Patent

active

055146996

ABSTRACT:
The invention provides pharmaceutical compounds of the formula: ##STR1## in which A - - - B is CH.sub.2 --CH.sub.2 or CH.dbd.CH;

REFERENCES:
patent: 5281619 (1994-01-01), Dell et al.
patent: 5284868 (1994-02-01), Dell et al.
CA 120:244547; (Bloxham, J. Chem. Soc. Perkin Trans. 1, 1993, 24, 3055-9).
CA 120:208603; (US 5281619, Jan. 25, 1994).
CA 120:106768; (EP 557075, Aug. 25, 1993).
CA 119:139102; (EP 537949, Apr. 21, 1993).
Elnagdi, et al., Naturfoschung B, 47(4), pp. 572-578 (1992).
Elagamey, et al. Indian Journal of Chemistry, 29B, 885-886 (1990).
Elagamey, et al., Collection Czechoslovak Chem. Commun., 53(7), 1534-1538 (1988).
Otto, et al., Monatshefte fur Chemi, 110, 115-119 (1979).
Otto, et al., Monatshefte fur Chemi, 110, 249-256 (1979).
Otto, et al., Arch. Pharm., 312(6), 548-550 (1979).
Abdel-Latif, Indian Journal of Chemistry, 29B, 664-666 (1990).
Sharanin, et al., Zhurnal Organicheskoi Khimii, 18, 9, 2003-2005 (1982).
Klokol, et al., Zhurnal Organicheskoi Khimii, 23, 2, 412-421 (1987).
Boxham, et al., J. Chem. Soc. Perkin Trans. 1, 24, 3055-3059 (1993).
Maybridge Chemical Company, Structure List No. 183, May 1989.
Maybridge Chemical Company, Exclusive Listing No. 1187/513684/13279, Nov. 6, 1987.
Maybridge Chemical Company, Exclusive Listing No. 288/513845/13684, Feb. 19, 1988.
Chemical Abstracts, Heterocycles, 85, 531 (1976).

Affiliated with

Also associated with

Rating

Pharmaceutical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1227541